XJPX
6823
Market cap269mUSD
Oct 09, Last price
3,550.00JPY
1D
2.75%
1Q
-0.98%
Jan 2017
119.14%
IPO
491.67%
Name
Rion Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rion Co., Ltd. develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan. The company’s audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom-made, and analog body aid instruments, as well as wireless and waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and recorders, and other products. The company’s particle counters comprise air and liquid-borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Key people
Kiminori Kato
President, Representative Director · since 2025
Kiyokatsu Iwahashi
Vice President, Director of Environmental Equipment Business, Chairman of Subsidiary, Representative Director · since 2025
Toshiyuki Hasumi
Executive Officer · since 2025
Maki Hirano
Executive Officer, Chief Director of Production · since 2025
Masato Kameyama
Executive Officer, President of Subsidiary · since 2025
Minori Miiri
Executive Officer · since 2022
Tadashi Munezaki
Executive Officer, Chief Director of Business Planning, Director of Director of Human Resources and General Affairs in Main Director of Human Resources and General Affairs Unit · since 2025
Yoshiyuki Narusawa
Executive Officer · since 2022
Masataka Ota
Executive Officer, Director of Medical Equipment Business · since 2025
Masaharu Oya
Executive Officer, Manager of Research and Development Office, Manager of Research and Development Office in Main Research and Development Office · since 2024
Kenichi Shimizu
Chairman of the Board · since 2022
Toshiyuki Shinozaki
Director of Particulate Measuring Instruments Business, Director · since 2024
Shinya Ejima
Independent Director · since 2025
Kikuko Hamada
Independent Director · since 2021
Kazunobu Takahashi
Independent Director · since 2023
Mari Ueda
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||